Disclosure Policy

It is the policy of the American Society of Nutrition, in compliance with the Standards for Integrity and Independence in Accredited Continuing Education to ensure that education presents learners with only accurate, balanced, and scientifically justified recommendations and protects learners from promotion, marketing, and commercial bias. ASN requires disclosure of all financial interest that the planning committee (including ASN staff) or faculty members have with ineligible companies. All faculty and contributors to this continuing education activity have disclosed any relevant financial relationship that may have direct bearing on the subject matter of this program. Specific disclosure information is in the course materials. 

The American Society for Nutrition supports fair and unbiased participation of individuals in its education activities. Any real or potential conflicts of interest must be identified and managed. All relevant financial relationships with commercial interests that directly impact and/or might conflict with ASN activities must be disclosed, or disclosure that no relevant financial relationships exist must be documented. Other relationships that could cause private interests to conflict with professional interests must also be disclosed. This policy is intended to openly identify any potential conflict so that participants in an education activity are able to form their own judgments about the presentation. In addition, disclosure must be made of presentations on drugs or devices or uses of drugs or devices that have not been approved by the Food and Drug Administration.

Monica Agarwal, MD    
The University of Alabama at Birmingham, Heersink School of Medicine
No relevant financial relationship(s) with ineligible companies to disclose

Jaclyn Albin, MD            
UT Southwestern Medical School
No relevant financial relationship(s) with ineligible companies to disclose

Anne Buison, PhD, RDN  
Saint Elizabeth University
No relevant financial relationship(s) with ineligible companies to disclose

David M. Duriancik, PhD
Lake Erie College of Osteopathic Medicine
No relevant financial relationship(s) with ineligible companies to disclose

Lisa Howley, PhD           
Association of American Medical Colleges
No relevant financial relationship(s) with ineligible companies to disclose

Laryssa Kaufman, MD  
Michigan State University College of Osteopathic Medicine
No relevant financial relationship(s) with ineligible companies to disclose

Martin Kohlmeier, MD, PhD, DFASN, FIANE 
SUNY Downstate
No relevant financial relationship(s) with ineligible companies to disclose

Carine M. Lenders, MD, MS, ScD      
Boston University Chobanian & Avedisian School of Medicine (retired) 
No relevant financial relationship(s) with ineligible companies to disclose.

Zhaoping Li, MD, PhD   
David Geffen School of Medicine at UCLA
No relevant financial relationship(s) with ineligible companies to disclose

Joan Salge Blake, EdD, RDN, LDN, FAND 
Boston University’s Sargent College of Health and Rehabilitation Sciences
No relevant financial relationship(s) with ineligible companies to disclose

Mark Speicher, PhD, MHA
American Association of Colleges of Osteopathic Medicine
No relevant financial relationship(s) with ineligible companies to disclose

Diane Stadler, PhD, RDN, LDN 
Oregon Health & Science University School of Medicine
No relevant financial relationship(s) with ineligible companies to disclose

Solenn Thircuir, PhD     
University of California, Santa Cruz 
No relevant financial relationship(s) with ineligible companies to disclose.

Gwen Twillman 
American Society for Nutrition 
No relevant financial relationship(s) with ineligible companies to disclose.

Virginia Uhley, PhD, RD     
Oakland University William Beaumont School of Medicine
No relevant financial relationship(s) with ineligible companies to disclose.